Krsnaa Diagnostics Ltd
KRSNAAKrsnaa Diagnostics Ltd
KRSNAAPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
45.94 | 3.41 | 0.29% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.91 | 6.64 | 0.47% |
Forecast & Ratings
Detailed Forecast from 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The Company provides diagnostic services. It provides radiology and pathology services for X-rays, CT scan, magnetic resonance imaging (MRI), mammography, tele reporting X-ray and all types of blood and urine investigations.
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Dr. Lal PathLabs Ltd
Global Health Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
---|---|---|---|---|---|---|---|---|
Total Revenue | 470.36 | 506.50 | 636.43 | 670.18 | ||||
Raw Materials | 0.00 | 0.00 | 0.00 | 494.73 | ||||
Power & Fuel Cost | 6.34 | 9.08 | 12.17 | |||||
Employee Cost | 54.15 | 74.56 | 111.47 | |||||
Selling & Administrative Expenses | 146.65 | 128.79 | 123.93 | |||||
Operating & Other expenses | 116.83 | 152.39 | 227.82 | |||||
EBITDA | 146.39 | 141.68 | 161.04 | 175.45 | ||||
Depreciation/Amortization | 41.39 | 53.78 | 74.55 | 80.28 | ||||
PBIT | 105.00 | 87.90 | 86.49 | 95.17 | ||||
Interest & Other Items | 18.49 | 7.70 | 16.49 | 19.85 | ||||
PBT | 86.51 | 80.20 | 70.00 | 75.32 | ||||
Taxes & Other Items | 18.12 | 18.09 | 13.17 | 15.23 | ||||
Net Income | 68.39 | 62.11 | 56.83 | 60.09 | ||||
EPS | 21.78 | 19.78 | 17.85 | 18.61 | ||||
DPS | 2.50 | 2.75 | 2.50 | 2.75 | ||||
Payout ratio | 0.11 | 0.14 | 0.14 | 0.15 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Krsnaa Diagnostics Ltd | 48.58 | 3.41 | 0.29% |
Apollo Hospitals Enterprise Ltd | 114.66 | 14.07 | 0.22% |
Max Healthcare Institute Ltd | 89.33 | 11.24 | 0.15% |
Fortis Healthcare Ltd | 77.64 | 5.43 | 0.16% |
Price Comparison
Compare KRSNAA with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Krsnaa Diagnostics Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Tata Small Cap Fund-Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 6.5307% | Percentage of the fund’s portfolio invested in the stock 2.03% | Change in the portfolio weight of the stock over the last 3 months 0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/56 (-2) |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.0442% | Percentage of the fund’s portfolio invested in the stock 1.17% | Change in the portfolio weight of the stock over the last 3 months -0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 28/47 (-6) |
Bandhan Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1291% | Percentage of the fund’s portfolio invested in the stock 0.41% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/172 (+10) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Dividend/Share
₹2.75
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
Krsnaa Diagnostics has received a Letter of Intent from Medical Superintendent, Sadar Hospital, Ranchi, Jharkhand for commission, install, operate and maintain the radiology services on public private partnership basis at Sadar Hospital, Purulia Road, Ranchi 834001. Powered by Capital Market - Live
Krsnaa Diagnostics has received a contract from Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS) for supply, install, commission, operate and maintain the radiology center and pathology laboratory services on public private partnership basis at Ranchi Institute of NeuroPsychiatry & Allied Sciences, Government of Jharkhand. Powered by Capital Market - Live
Krsnaa Diagnostics announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live
Net profit of Krsnaa Diagnostics rose 22.40% to Rs 17.92 crore in the quarter ended June 2024 as against Rs 14.64 crore during the previous quarter ended June 2023. Sales rose 21.96% to Rs 170.23 crore in the quarter ended June 2024 as against Rs 139.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales170.23139.58 22 OPM %25.0622.47 - PBDT44.6733.63 33 PBT23.2017.89 30 NP17.9214.64 22 Powered by Capital Market - Live
Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
Krsnaa Diagnostics shares rise 5% on order win from MP Govt to set up MRIs
Data Patterns, Anupam Rasayan, Trident, Krsnaa Diagnostics Q4 Results Today — Earnings Estimates
Krsnaa Diagnostics Shares Jump 10% After Rajasthan High Court Reinstates Contract
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant